IFM Therapeutics
PrivateLast Round
VC Round
Dec 2, 2019
Total Funding Raised
$58M
Company Overview
IFM Therapeutics operates in Healthcare & Life Sciences and is based in Boston, Massachusetts. Its latest recorded funding round was a VC Round in December 2019.
IFM Therapeutics is a biopharmaceutical company that develops small molecule medicines aimed at enhancing immunotherapy by precisely targeting the innate immune system to address complex issues in treating inflammatory and autoimmune disorders as well as cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
IFM Therapeutics Comparables
Compare IFM Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ventus Therapeutics | 89% | |
| Olatec Therapeutics | 86% | |
| Inflammasome Therapeutics | 81% |
For institutional investors. Book with your work email.
IFM Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Dec 2, 2019 | ||||
| Series A | Jul 19, 2018 | ||||
| M&A | Aug 3, 2017 | ||||
| Series A | Jun 21, 2016 | ||||
| Seed | Oct 1, 2015 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
IFM Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Omega Funds | VC Round |
| Abingworth | Series A, VC Round |
| Atlas Venture | Series A, VC Round, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 2, 2019
$56M round led by Omega Funds.
- Jul 19, 2018
$31M round with participation from Abingworth and Atlas Venture.
For institutional investors. Book with your work email.
IFM Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about IFM Therapeutics's valuation, stock price, and market status.
Is IFM Therapeutics a public or private company?
IFM Therapeutics is a private company.
What is the current stock price of IFM Therapeutics?
IFM Therapeutics is a private company, so its shares have no public market price. Caplight tracks IFM Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is IFM Therapeutics worth (valuation)?
Valuation information for IFM Therapeutics is not publicly available.
Can I buy IFM Therapeutics stock?
IFM Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was IFM Therapeutics's last funding round?
IFM Therapeutics's most recent funding round was VC Round on December 2, 2019.
Who are the main investors in IFM Therapeutics?
Key investors in IFM Therapeutics include Omega Funds, Abingworth, Atlas Venture.
Will IFM Therapeutics IPO soon?
No public IPO plans have been announced for IFM Therapeutics.
How can I track IFM Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in IFM Therapeutics's shares on secondary markets.